Cited by 664Adipokines, Inflammation, and Metabolic DiseasesLipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.

C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring Study

Rutter, Martin K., Meigs, James B., Sullivan, Lisa M., D’Agostino, Ralph B., Wilson, Peter W.F.·2004·Circulation

DOI 10.1161/01.cir.0000136581.59584.0e

Open this paper in CoChat — free account

Abstract

Background— Inflammation (assessed by C-reactive protein [CRP]) and the metabolic syndrome (MetS) are associated with cardiovascular disease (CVD), but population-based data are limited. Methods and Results— We assessed the cross-sectional relations of CRP to the MetS (National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Adult Treatment Panel III definition) in 3037 subjects (1681 women; mean age, 54 years) and the utility of CRP and the MetS to predict new CVD events (n=189) over 7 years. MetS (≥3 of 5 traits) was present in 24% of subjects; mean age-adjusted CRP levels for those with 0, 1, 2, 3, 4, or 5 MetS traits were 2.2, 3.5, 4.2, 6.0, or 6.6 mg/L, respectively ( P trend <0.0001). In persons with MetS, age-adjusted CRP levels were higher in women than men (7.8 versus 4.6 mg/L; P <0.0001). MetS and baseline CRP were individually related to CVD events (for MetS: age-sex-adjusted hazard ratio [HR], 2.1; 95% CI, 1.5 to 2.8; for highest versus lowest CRP quartile: HR, 2.2; 95% CI, 1.4 to 3.5). Greater risk of CVD persisted for MetS and CRP even after adjustment in a model including age, sex, MetS (HR, 1.8; 95% CI, 1.4 to 2.5), and CRP (HR, 1.9; 95% CI, 1.2 to 2.9). The c-statistic associated with the age- and sex-adjusted model including CRP was 0.72; including MetS, 0.74; and including CRP and MetS, 0.74. Conclusions— Elevated CRP levels are related to insulin resistance and the presence of the MetS, especially in women. Although discrimination of subjects at risk of CVD events using both MetS and CRP is not better than using either phenotype alone, both CRP and MetS are independent predictors of new CVD events.

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000136581.59584.0e

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial Dysfunction: A Potential Role for Cytokines Originating From Adipose Tissue?
Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465
Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,366
Self-citation
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women
Ridker, P. M., Buring, J. E., Cook, N. R., & Rifai, N. (2003) · Circulation · doi:10.1161/01.cir.0000055014.62083.05 · Cited by 2,292
Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study
Sattar, N., Gaw, A., Scherbakova, O., Ford, I., O’Reilly, D. S. J., Haffner, S. M., Isles, C., Macfarlane, P. W., Packard, C. J., Cobbe, S. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000080897.52664.94 · Cited by 1,506
Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study
Schmidt, M. I., Duncan, B. B., Sharrett, A. R., Lindberg, G., Savage, P. J., Offenbacher, S., Azambuja, M. I. R., Tracy, R. P., & HEISS, G. M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01046-6 · Cited by 1,080
Elevated Levels of Acute-Phase Proteins and Plasminogen Activator Inhibitor-1 Predict the Development of Type 2 Diabetes
Festa, A., D’Agostino, R., Tracy, R. P., & Haffner, S. M. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1131 · Cited by 1,057
Self-citation
Is Type II diabetes mellitus a disease of the innate immune system?
Pickup, J. C., & Crook, M. A. (1998) · Diabetologia · doi:10.1007/s001250051058 · Cited by 1,042

Show all 36 references

Research works printed but not linked: 7

10.1161/atvb.19.4.972 · DOI
10.1161/circ.102.1.42 · DOI
10.1161/str.32.11.2575 · DOI
1998, Diabetologia, 4, 1241
2003, Clin Chem Lab Med, 41, 1120
10.1210/jcem.86.9.7873 · DOI · Paper page
10.1001/jama.1991.03460050081025 · DOI

Sorted by citations

Items 501–600 of 662

Clinical Use and Pathogenetic Basis of Laboratory Tests for the Evaluation of Primary Arterial Hypertension
Seccia, T. M., & Rossi, G. P. (2005) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360500295600 · Cited by 6
Gender-Specific Care of Diabetes
Szalat, A., & Raz, I. (2007) · Women s Health · doi:10.2217/17455057.3.6.735 · Cited by 7
“Women with metabolic syndrome may have a worse cardiovascular mobidity and mortality because of worse inflammation status determined by higher CRP levels than in men [97], more arterial stiffness [98], carotid stenosis [99], and a higher prevalence of ischemic strokes [100] than men with the same profile.”
Background
Loss of significant association between high-sensitivity C-reactive protein (hs-CRP) and metabolic syndrome after adjustment for waist circumference found in 2022 Korea National Health and Nutrition Examination Survey data
Kim, B., Ryu, S.-Y., Han, M. A., & Choi, S.-W. (2025) · Journal of PHYSIOLOGICAL ANTHROPOLOGY · doi:10.1186/s40101-025-00396-5 · Cited by 5
“High-sensitivity C-reactive protein (hs-CRP) is a liver-derived protein that serves as a biomarker for systemic inflammation [11, 12].”
Hormones, heat, and health: a comprehensive review of sex-based differences in brown and beige fat biology
Shashank, C. G., Mandali, R., & Wankhade, U. D. (2025) · Biology of Sex Differences · doi:10.1186/s13293-025-00787-4 · Cited by 6
“Inflammation, assessed by CRP levels, was a stronger predictor of metabolic syndrome in women than men [163].”
Metabolic Syndrome - A Bomb with Delayed Reaction
F, G. S. E. (2015) · Journal of Bioequivalence & Bioavailability · doi:10.4172/jbb.1000231 · Cited by 5
Assessment of the Patient With Diabetes for Coronary Heart Disease Risk: Review and Personal Reflection
FITCHETT, D. H. (2007) · Canadian Journal of Diabetes · doi:10.1016/s1499-2671(07)12011-6 · Cited by 5
Attainment of Normal Lipid Levels Among Patients on Lipid-Modifying Therapy in Hong Kong
Ambegaonkar, B. M., Chirovsky, D. R., Tse, H., Lau, Y. K., Tomlinson, B., Li, S. K., Yue, C. S., Wong, T. H., Choi, M. C., Tunggal, P., et al. (2012) · Advances in Therapy · doi:10.1007/s12325-012-0017-9 · Cited by 5
Ameliorative effect of Gongronema latifolium leaf extract on alloxan-induced diabetic cardiomyopathy in Wistar rats model
Okesola, M. A., Ojo, O. A., Onikanni, S. A., Ajiboye, B. O., Oyinloye, B. E., Agboinghale, P. E., & Kappo, A. P. (2020) · Comparative Clinical Pathology · doi:10.1007/s00580-020-03134-8 · Cited by 5
“Increased serum CRP in alloxan-induced diabetic rats in the present study was in agreement with the findings of earlier studies revealing increased serum CRP levels in diabetic patients (Rutter et al. 2004).”
Result
Effect of Pre-Germianted Brown Rice on Metabolism of Glucose and Lipid in Patients with Diabetes Mellitus Type 2
Hayakawa, T., Suzuki, S., Kobayashi, S., Fukutomi, T., Ide, M., Tsuneo, O. H. N. O., OHKOUCHI, M., Mitsuko, T. A. K. I., Miyamoto, T., NIMURA, T., et al. (2009) · JOURNAL OF THE JAPANESE ASSOCIATION OF RURAL MEDICINE · doi:10.2185/jjrm.58.438 · Cited by 5
Association of Metabolic Syndrome with Urinary Albumin Excretion, Low-grade Inflammation, and Low Glomerular Filtration Rate among Non-diabetic Japanese Subjects
Abe, R., Minami, J., Ohrui, M., & Ishimitsu, T. (2009) · Internal Medicine · doi:10.2169/internalmedicine.48.2471 · Cited by 5
Subgroups With Metabolic Syndrome Show Different Association With Ischemic Heart Disease and Stroke; Findings of Iran STEPS Survey 2021
Koolaji, S., Azadnajafabad, S., Yoosefi, M., Ahmadi, N., Golestani, A., Ghasemi, E., Dilmaghani‐Marand, A., Rezaei, N., Kazemi, A. S., Rezaei, N., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.039240 · Cited by 4
“11,34,35 Although not all previous studies applied the same MetS definition, a community-based study in Iran showed that the risk of CVD is not significantly different between various definitions 33 and not dependent on the WC threshold including 94/80 and 102/88, 36 which are the thresholds used…”
The Prognostic Value of Complete Blood Count-Derived Inflammatory Indicators for All-Cause Mortality in Type 2 Diabetes Mellitus: A Retrospective Cohort Study
Li, B., Xu, Y., Zhu, H., He, Q., Yin, Q., Wu, M., Zhang, J., & Cao, Y. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s546455 · Cited by 4
Review: Cardiovascular risk assessment in the metabolic syndrome, screening for subclinical disease, and implications for treatment
Wong, N. D. (2005) · The British Journal of Diabetes · doi:10.1177/14746514050050060201 · Cited by 4
Association of C-reactive protein and arterial hypertension
Patidar, O. P., Bhargava, A., & gupta, D. (2015) · International Journal of Advances in Medicine · doi:10.5455/2349-3933.ijam20150511 · Cited by 4
The conceptualisation of cardiometabolic disease policy model in the UK
Putri, S., Ciminata, G., Lewsey, J., Jani, B., McMeekin, N., & Geue, C. (2024) · BMC Health Services Research · doi:10.1186/s12913-024-11559-y · Cited by 5
Fatty liver and abdominal fat relationships with high C-reactive protein in adults without coronary heart disease
Cardoso-Saldaña, G. C., Medina-Urrutia, A. X., Posadas‐Romero, C., Juárez-Rojas, J. G., Galarza, E. J., Vargas‐Alarcón, G., & Posadas‐Sánchez, R. (2015) · Annals of Hepatology · doi:10.1016/s1665-2681(19)30760-4 · Cited by 4
Operative risk factors in the metabolic syndrome: Is it lipids and high blood pressure or are there direct vascular effects of insulin resistance and obesity?
Ukkola, O. H. (2006) · Current Cardiology Reports · doi:10.1007/s11886-006-0100-4 · Cited by 4
A Possible Role for Chemerin; a Novel Adipokine in the Haemostatic and Atherogenic Disorders Related to Obesity in White Albino Rats
Morgan, E. N., & Edrees, H. M. (2013) · The Open Obesity Journal · doi:10.2174/1876823720130703010 · Cited by 4
“For instance, C-reactive protein levels were higher among people who were physically inactive, [46, 47] and were more obese [48].”
Background
Metabolic syndrome abating the beneficial effect of pravastatin treatment on adhesion of endothelium by monocytes in subjects with hypercholesterolemia
Lee, I., Lee, W., Ou, H., Huang, C., & Sheu, W. H. (2009) · Metabolism · doi:10.1016/j.metabol.2008.10.019 · Cited by 4
“Metabolic syndrome, associated with inflammation, plays an important role in atherosclerosis and coronary heart disease [10-12].”
Background
Prognostic Role of Metabolic Syndrome in the Elderly is Not Greater Than the Sum of Its Components
Mazza, A., Pessina, A. C., Zamboni, S., & Casiglia, E. (2010) · Aging Health · doi:10.2217/ahe.10.9 · Cited by 4
“The risk of CV disease found in the CHS is similar to that of the Framingham Offspring Study (FOS) [81], the Atherosclerosis Risk in Communities (ARIC) study [82], the National Health and Nutrition Examination Survey Mortality Study (NHANES) [83], the SAHS [84] and the Finnish population of Kuopio [85].”
Result
Association of nocturnal penile rigidity with testosterone, metabolic syndrome, and other variables: A prospective cross-sectional pilot study
Rajmil, O., Fernández-Miró, M., Blasco-Moreno, A., Arrús, J. A., Montañés, R., & Rodrı́guez-Espinosa, J. (2011) · Actas Urológicas Españolas (English Edition) · doi:10.1016/j.acuroe.2011.03.012 · Cited by 4
The Metabolic Syndrome: Time for a Critical Appraisal
Kahn, R., Buse, J. B., Ferrannini, E., & Stern, M. P. (2006) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2006-12-2-99-116 · Cited by 5
Síndrome metabólico
Sánchez, A. V., García, G. M., & Narankievickz, D. (2017) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2017.10.002 · Cited by 7
The effects of estimated glucose disposal rate and high sensitivity C-reactive protein on risk of incident cardiovascular diseases in middle-aged and elderly Chinese adults: a nationwide prospective cohort study
Xu, L., Ma, J., & Xu, Y. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02653-z · Cited by 3
“However, it is important to note that while hsCRP is widely acknowledged as a risk indicator for CVD [20, 48, 49], CRP do not constitute a pathogenic factor for CVD.”
Obesity and the Metabolic Syndrome
Grandjean, P. W. (2012) · CRC Press eBooks · doi:10.1201/b12085-17 · Cited by 3
Obstructive Sleep Apnea Syndrome: Implications in Cardiovascular Disease
Zamarrón, C., Matias, F., & Egea, C. (2009) · Current Respiratory Medicine Reviews · doi:10.2174/157339809790112492 · Cited by 3
Aterosclerosis: biomarcadores plasmáticos emergentes
Benozzi, S. F., & Coniglio, R. I. (2010) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 3
Evaluation of Applicability of Novel Markers of Metabolic Syndrome in Adult Men
Tomasiuk, R. (2022) · American Journal of Men s Health · doi:10.1177/15579883221108895 · Cited by 3
“This observation contradicts the report by Rutter et al. (2004), which shows an increase in CRP levels in the presence of MetS.”
Result
Metabolic syndrome in inflammatory rheumatic diseases
Malesci, D., Valentini, G., & MONTAGNA, G. L. (2011) · Reumatismo · doi:10.4081/reumatismo.2006.169 · Cited by 3
“L’evidenza che l’infiammazione sia alla base del processo aterosclerotico (34) e che la PCR sia un fattore indipendente di rischio CV (35), correlato all’insulino-resistenza (36), ha spinto alla dimostrazione della sua alta predittività di CVD, simile a quella della MetS (37).”
Background
Hip Circumference is an Important Predictor of Plasma C-reactive Protein Levels in Overweight and Obese Taiwanese Women
Jou, H., Hsu, I.-P., Ling, P., Lin, C.-T., Tsai, S.-T., Huang, H.-T., & Wu, S. (2006) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/s1028-4559(09)60227-8 · Cited by 3
Use of High-Sensitivity C-Reactive Protein for Risk Assessment
Campbell, C. Y., Musunuru, K., Mora, S., & Blumenthal, R. S. (2009) · Elsevier eBooks · doi:10.1016/b978-141605469-6.50017-2 · Cited by 3
The metabolic syndrome X or insulin resistance syndrome
Nikolic, A., Nikolic, D., & Stanimirović, V. (2007) · Vojnosanitetski pregled · doi:10.2298/vsp0701045n · Cited by 3
Cystatin C: An underexplored biomarker that goes beyond renal function
Andrade, M. J. (2014) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2014.07.001 · Cited by 3
“A number of recent studies have demonstrated a correlation between inflammatory mediators and MetS components, and an association between inflammatory markers and the severity of MetS has also been reported.(10) These indicators of inflammation in MetS may be early markers of the development of CVD.”
Background
Effect of Exercise Training on Metabolic Syndrome z-score : the Association of C- reactive protein
Gates, T. (2015) · The Scholarship East Carolina University's Institutional Repository (East Carolina University) · Cited by 3
The metabolic syndrome: what have we learned?
Sheu, W. H. (2004) · PubMed · Cited by 3
Polycystic Ovary Syndrome
Sattar, N. A. (2011) · doi:10.1002/9781444347319.ch16 · Cited by 3
Asociación de la rigidez peneana nocturna con testosterona, síndrome metabólico y otras variables: un estudio piloto prospectivo transversal
Rajmil, O., Fernández-Miró, M., Blasco-Moreno, A., Arrús, J. A., Montañés, R., & Rodrı́guez-Espinosa, J. (2011) · Actas Urológicas Españolas · doi:10.4321/s0210-48062011000800005 · Cited by 2
Associations of ALT/AST, a marker of hepatosteatosis, with pulse rate in young women and with blood pressure in middle-aged women independently of abdominal fat accumulation and insulin resistance
Minato-Inokawa, S., Tsuboi-Kaji, A., Honda, M., Takeuchi, M., Kitaoka, K., Kurata, M., Wu, B., Kazumi, T., & Fukuo, K. (2024) · Diabetology International · doi:10.1007/s13340-023-00689-z · Cited by 2
“Studies have provided evidence that a wider constellation of disorders may be part of the metabolic syndrome cluster, including subclinical inflammation [2], oxidative stress [3], sympathetic overactivity [4], nonalcoholic fatty liver disease (NAFLD), [5] and hypercoagulability [6].”
C-Reactive Protein as a Tool for Risk Assessment in Primary Prevention
Bassuk, S. S., & Ridker, P. M. (2006) · Humana Press eBooks · doi:10.1007/978-1-59745-051-5_16 · Cited by 2
“In a 7-yr follow-up of 3037 men and women without diabetes in the Framingham Offspring Study, persons in the highest quartile of hsCRP had nearly twice the risk of developing CVD than did those in the lowest quartile after adjustment for age, sex, and the presence of the metabolic syndrome (hsCRP ≥4.5 vs 77 ).”
BackgroundInfluential
COPD and Sleep Apnea Syndrome – Impact and Interaction of Coexisting Disease
Sanz, C. Z., Rábade, C., de Lucas, E. Z., Morete, E., & Matias, F. D. C. (2014) · InTech eBooks · doi:10.5772/57594 · Cited by 2
“C-reactive protein is an important serum marker of inflammation with major implications for cardiovascular morbidity and atherogenesis (Rutter et al., 2004).”
Background
Association of Metabolic Syndrome with Serum Adipokines in Community-Living Elderly Japanese Women: Independent Association with Plasminogen Activator-Inhibitor-1
Takeuchi, M., Tsuboi, A., Kurata, M., Fukuo, K., & Kazumi, T. (2015) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0014 · Cited by 2
Cardiometabolic risk in high–normal blood pressure state: mechanistic insights
Grassi, G. M., & Mancia, G. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e32831ddead · Cited by 2
The metabolic syndrome: Is it still alive?
Bonora, E. (2007) · International Congress Series · doi:10.1016/j.ics.2007.03.020 · Cited by 2
Association of dietary fiber with high sensitivity C-reactive proteinin type 2 diabetes mellitus
Begum, I. A., Sen, M., Afrin, S. F., Moutushi, S. S., Islam, M. A., & Rahman, M. H. (2012) · Bangladesh Journal of Medical Science · doi:10.3329/bjms.v11i2.11434 · Cited by 2
Síndrome Metabólica: o risco cardiovascular é maior que o risco dos seus componentes isoladamente? Metabolic Syndrome: is cardiovascular risk higher than for its individual components?
Junqueira, C., da Costa, G. M., & Magalhães, M. E. C. (2011) · Cited by 2
Gender Differences in Stroke
Gottesman, R. F., & Hillis, A. E. (2010) · Principles of Gender-Specific Medicine · doi:10.1016/b978-0-12-374271-1.00011-3 · Cited by 2
Epicardial fat in patients with metabolic syndrome
Elsaidy, M. A., & Shendy, S. M. (2017) · Journal of Indian College of Cardiology · doi:10.1016/j.jicc.2017.01.003 · Cited by 2
Hipertensión arterial y síndrome metabólico
Fort, A. C., Arribas, J. M., & Ezquerra, E. A. (2006) · Hipertensión · doi:10.1016/s0212-8241(06)71715-7 · Cited by 2
Metabolic Syndrome and Cardiovascular Disease
Malik, S., & Wong, N. D. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1366-4.00022-6 · Cited by 2
Insulin Resistance and Coronary Heart Disease
Laakso, M., & Kuusisto, J. (2005) · Elsevier eBooks · doi:10.1016/b978-84-8174-892-5.50023-1 · Cited by 2
Endothelial Dysfunction, Inflammation, and Exercise
Doupis, J., Schramm, J. C., & Veves, A. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-260-1_6 · Cited by 2
Use of High-Sensitivity C-Reactive Protein for Risk Assessment
Martin, S. S., Johnson, A. E., & Blumenthal, R. S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-28786-9.00012-8 · Cited by 2
LEFT ATRIUM AND MODERN VIEWS ON PATHOGENESIS OF ESSENTIAL HYPERTENSION
Барсуков, А. В., Владимирович, Г. Д., Zobnina, N. P., Сергеевна, Т. М., & Свеклина, Т. С. (2013) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2013-19-1-18-26 · Cited by 2
The atheroprotective effects of genistein in hypercholestrolemic male rabbit
Mudhafar, A. W. A., Hadi, N. R., Wasfi, R. M. A. H., & Mohammed, Z. (2018) · Journal of Contemporary Medical Sciences · doi:10.22317/jcms.v4i4.488 · Cited by 2
Biomarcadores emergentes para la prevención primaria de la enfermedad cardiovascular y del accidente cerebrovascular
Myers, G. L. (2010) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 2
The Effects of Isolated versus Multiple Lipid Disorders on Resource Utilization among Metabolic Syndrome Patients with Lipid Abnormalities despite Lipid-Modifying Treatment
Ambegaonkar, B. M., Chirovsky, D. R., Wu, W. K., Colclough, H., Milligan, G., & Sazonov, V. (2010) · Cardiology · doi:10.1159/000318022 · Cited by 2
“However, in light of recent evidence suggesting that patients with metabolic syndrome (MetS) are at increased risk of developing CHD [ ,”
Background
Type 2 diabetes and cognition: Neuropsychological sequelae of vascular risk factors in the ageing brain
van den Berg, E. (2004) · Utrecht University Repository (Utrecht University) · Cited by 2
Transition nutritionnelle et double fardeau de la malnutrition chez des adultes de Ouagadougou au Burkina Faso (Afrique de l’Ouest)
Zeba, A. N. (2012) · doi:10.71781/30721 · Cited by 2
Elevated glycoprotein acetyl levels in adolescence and early adulthood predict adverse cardiometabolic profiles and risk of metabolic syndrome in up to 10 year follow-upPreprint
Chiesa, S. T., Charakida, M., Georgiopoulos, G. A., Roberts, J., Stafford, S. J., Park, C. M., Mykkänen, J., Kähönen, M. A. P., Lehtimäki, T. J., Ala‐Korpela, M., et al. (2020) · medRxiv · doi:10.1101/2020.09.30.20204479 · Cited by 2
Role of hs-CRP measurements in the current cardiovascular risk assessment
Levinson, S. S., & Elin, R. J. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.01.010 · Cited by 2
Inflammation
(2012) · Wiley eBooks · doi:10.1002/9781118480045.ch9 · Cited by 2
The Effect of Type, Duration and Intensity of Exercise on Inflammatory Markers CRP, IL-6 and IL-18 in Metabolic Syndrome Patients: A Systematic Review
Das, S., Naina-Mohamed, I., Zulfarina, M. S., Salim, H. H., Zawawi, A., Thevaraj, T., Ku-Ahmad-Nasir, K. N., Zhou, D. K., & Teoh, S. L. (2021) · Sains Malaysiana · doi:10.17576/jsm-2021-5007-14 · Cited by 1
Sagittal Abdominal Diameter as an Anthropometric Measure of Cardiovascular and Graft Loss Risk in Renal Transplant Recipients
Bal, Z., Uyar, M. E., Tutal, E., Guliyev, O., Çolak, T., Sezer, S., & Haberal, M. A. (2015) · Transplantation Proceedings · doi:10.1016/j.transproceed.2015.01.027 · Cited by 1
High-Sensitivity C-Reactive Protein and the Metabolic Syndrome
Song, Y., Liu, S., & Manson, J. E. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-116-5_9 · Cited by 1
Complications of Obesity: Metabolic Syndrome
Osganian, S. K., de Ferranti, S. D., Duggan, C. R., Watkins, J. B., & Walker, W. A. (2008) · Cited by 1
Significant associations between hemostatic/fibrinolytic systems and accumulation of cardiovascular risk factors in Japanese elementary schoolchildren
Lin, L., Horigome, H., Kato, Y., Kikuchi, T., Nakahara, S., & Sumazaki, R. (2014) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000000187 · Cited by 1
Gender Differences Regarding Novel Biomarkers and Metabolic Risk Factors in Metformin Treated Type 2 Diabetic Patients
Wändell, P. E. (2012) · The Open Diabetes Journal · doi:10.2174/1876524601205010013 · Cited by 1
“Gender differences have been described, with CRP related to metabolic disturbances among women but not men [32, 33].”
Background
Metabolic syndrome may increase operative mortality in patients undergoing coronary artery bypass graft surgery
Tung, S. R., Collard, C. D., & Pan, W. (2008) · Future Lipidology · doi:10.2217/17460875.3.1.27 · Cited by 1
“The incidence of acute ischemic events (myocardial infarction [MI], stroke or MI/stroke) is increased by the MS [8].”
Background
Erythrocyte Sedimentation Rate, C-Reactive Protein and Procalcitonin in Infections of the Spine and Infections in Spinal Cord Injury Patients
Buensalido, J. A. L., & Reyes, M. P. (2015) · The Open Infectious Diseases Journal · doi:10.2174/1874279301509010001 · Cited by 1
“This has led to so much more chronic diseases, including diabetes, dyslipidemia and cardiovascular disease (CVD) [30, 38, 39], in these chronic patients.”
Background
Attainment of Goal and Normalized Lipid Levels With Lipid-Modifying Therapy in Malaysia
Hsu, T.-Y., Chirovsky, D. R., Moy, F. M., & Ambegaonkar, B. M. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.02.004 · Cited by 1
Risk Prediction in Cardiovascular Medicine Cardiovascular Risk Prediction Basic Concepts, Current Status, and Future Directions
Lloyd‐Jones, D. M. (2016) · Cited by 1
Enfermedad psiquiátrica y síndrome metabólico. Énfasis en el trastorno esquizofrénico
Joffre-Velázquez, V. M., García-Maldonado, G., Saldívar-González, A. H., Lin-Ochoa, D., & Sosa-Herrera, J. (2009) · Revista Médica Del Hospital General De México · Cited by 1
Ocena wybranych laboratoryjnych parametrów stanu zapalnego u chorych na pierwotne nadciśnienie tętnicze Assessment of laboratory markers of inflammation in patients with primary hypertension
Baszczuk, A., Pupek‐Musialik, D., & Cymerys, M. (2011) · Cited by 1
The Relationships between Metabolic Syndrome with Liver Function Test, Pulmonary Function Test, White Blood Cell Count, and Ferritin: The Fifth Korean National Health and Nutrition Examination Survey 2010
Lee, C., Lee, K., Park, T., Park, D.-J., Lee, H.-J., Jung, Y.-H., & Kim, D.-H. (2014) · Cited by 1
Evaluation of Ceruloplasmin Oxidase Activity and C-Reactive Protein in the Sera of Patients With Diabetes Mellitus
Nasif, Z. N. (2010) · Cited by 1
The Role of Noninvasive Imaging for Detection High Risk Patients with Subclinical Atherosclerosis
Hristová, K. (2016) · Archives of Clinical Hypertension · doi:10.17352/ach.000005 · Cited by 1
High Sensitive C-Reactive Protein as a Pro-inflammatory marker for the components of metabolic syndrome
Arulanantham, R., Babu, T., & Radhakrishnan, S. (2016) · International Journal of Medical Research and Review · doi:10.17511/ijmrr.2016.i06.05 · Cited by 1
Metabolic syndrome in patients with autoimmune inflammatory rheumatisms
Amaricai, E. C., Căţan, L., Popa, D., Dragoi, M., & Nemes, D. (2018) · Biomedical Research - India · doi:10.4066/biomedicalresearch.62-18-412 · Cited by 1
An update on inflammatory markers in metabolic syndrome
Giri, A. P., & Lokesh, S. (2021) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20212111 · Cited by 1
“Limited data on the association of low-grade inflammation with the metabolic syndrome are available in the elderly, especially from long-term studies.(28)”
Background
Glucose Homeostasis in Relation to Neutrophil Mobilization in Smokers with COPD
Pournaras, N., Andersson, A., Kovach, M. A., Padra, M., Che, K., Brundin, B., Yoshihara, S., Bozinovski, S., Lindén, S. K., Jansson, P., et al. (2022) · International Journal of COPD · doi:10.2147/copd.s353753 · Cited by 1
Could Serum YKL-40 Level be the New Cardiovascular Risk Prediction Model?
Ceyhun, G., Altınkaya, O., Şeker, M. C., & Kızıltunç, A. (2024) · Cor et Vasa · doi:10.33678/cor.2024.056 · Cited by 1
Residual Risk and Biology of the Disease: Implications for Plaque Imaging
Kataoka, Y., & Nicholls, S. J. (2014) · Contemporary cardiology · doi:10.1007/978-1-4939-0572-0_1 · Cited by 1
Outpatient Diabetic Care in a Public Central Hospital: Patient Characteristics, Therapeutic Regimens and Results
Martins, J. M., Vale, S., Martins, A., Gomes, A. R., Vicente, L., & Caldeira, J. (2014) · Journal of Endocrinology and Metabolism · doi:10.14740/jem.v4i1-2.205 · Cited by 1
PREVALENCE OF METABOLIC SYNDROME AND COMORBID CONDITIONS IN INMATES OF OLD AGE HOMES
N., S. R. K., & Subbalakshmi, N. K. (2012) · Journal of Health and Allied Sciences NU · doi:10.1055/s-0040-1703607 · Cited by 1
Predicting cardiovascular complications after liver transplantation
Gurram, H., Jo, J., & VanWagner, L. B. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-817394-7.00002-4 · Cited by 1
Lipoprotein-associated phospholipase A2 (Lp-PLA2) Impact and role as cardiovascular risk marker
Persson, M. (2008) · Lund University Publications (Lund University) · Cited by 1
Hipertensión arterial y síndrome metabólico
Fort, A. C., Arribas, J. M., & Ezquerra, E. A. (2006) · Hipertensión y Riesgo Vascular · doi:10.1016/s1889-1837(06)71590-2 · Cited by 1
Markers of subclinical atherosclerosis and arterial stiffness in type 2 diabetes
Dahlén, E. M. (2011) · DiVA (Linkoping University) · Cited by 1
Effect of Obesity on the Traditional and Emerging Cardiovascular Disease Risk Factors in African American Women
Henry-Okafor, Q. (2009) · doi:10.21007/etd.cghs.2009.0133 · Cited by 2
RELATIONSHIP BETWEEN THE METABOLIC SYNDROME AND CORONARY ARTERY DISEASE IN PATIENTS WITH STABLE ANGINA
Sadeghi, M., Yaraghi, M. G., Saneei, H., Rozati, G., Rouhafza, H. R., & Talaei, M. (2006) · Cited by 1
An evaluation of a chronic disease outreach program (CDOP) - a primary care and tertiary care kidney and cardiovascular prevention, detection and management program
Katz, I. J. (2011) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg) · Cited by 1
DIFFERENT COMBINATIONS OF THE METABOLIC SYNDROME CRITERIA AND CARDIOVASCULAR DISEASEPreprint
Lind, L. (2023) · medRxiv · doi:10.1101/2023.10.11.23296877 · Cited by 1
Can antioxidant-rich berries improve risk factors associated with cardiovascular disease in postmenopausal smokers?
Teeple, J. A. (2011) · Journal of the Arkansas Academy of Science
Rischio cardiovascolare e rischio cardiometabolico: una valutazione epidemiologica
Vanuzzo, D., Pilotto, L., Mirolo, R., & Pirelli, S. (2008) · Giornale italiano di cardiologia · doi:10.1714/669.7808
Metabolic syndrome, diabetes and heart failure
Merchán, A. (2005) · Acta Médica Colombiana
CHRONIC STRESS, INFLAMMATION, AND PROGRESSION OF CAROTID ARTERY ATHEROSCLEROSIS: A MEDIATION MODEL
Janicki, D. L. (2006) · D-Scholarship@Pitt (University of Pittsburgh)
Role of Innate Immune Dysregulation in Diabetic Heart Failure
Dokken, B. B., & McDonagh, P. F. (2007) · doi:10.1002/9780470692325.ch19
Role of intra-cellular glucocorticoid regulation in vascular lesion development
Iqbal, J. (2010) · ERA
The metabolic syndrome and cardiovascular disease: the CODAM study
Jacobs, M. (2011) · Research Publications (Maastricht University) · doi:10.26481/dis.20110929mj
Multivariable Evaluation of Candidates for Cardiovascular Disease
D’Agostino, R. B., & Kannel, W. B. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6705-2_1
Self-citation

Authors: Rutter, M. K., Meigs, J. B., Sullivan, L. M., D’Agostino, R. B., & Wilson, P. W. F.
Affiliations: Boston University (US)
ORCID: Rutter, Martin K.
Meigs, James B.
Sullivan, Lisa M.
D’Agostino, Ralph B.
Wilson, Peter W.F.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2004-07-27
Volume: 110
Issue: 4
Pages: 380-385
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.0000136581.59584.0e
OpenAlex: W1983997573
Cited by: 664
References: 36
Citations by year: 2026: 4 · 2025: 7 · 2024: 9 · 2023: 15 · 2022: 19 · 2021: 9 · 2020: 8 · 2019: 11 · 2018: 15 · 2017: 13 · 2016: 19 · 2015: 20 · 2014: 36 · 2013: 36 · 2012: 26
FWCI: 48.38
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Research Explorer (The University of Manchester) (submittedVersion)
Funders: National Institutes of Health (n01hc25195-41-0-1)
National Heart, Lung, and Blood Institute (R01HL073272, N01‐HC25195, R01-HL 073272-01)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: C-reactive protein, metabolic syndrome, cardiovascular risk prediction, inflammation, insulin resistance, sex differences, Framingham Offspring Study, cardiovascular events, risk discrimination, cardiovascular risk in women, NCEP ATP III criteria, Framingham risk score, Framingham risk equation
MeSH terms: Adult, Aged, Aged, 80 and over, C-Reactive Protein, Cardiovascular Diseases, Cross-Sectional Studies, Female, Follow-Up Studies, Humans, Inflammation, Insulin Resistance, Male, Middle Aged, Predictive Value of Tests, Risk, Sex Factors, Cohort Studies, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks